Aging Affects the Efficacy of Platelet-Rich Plasma Treatment for Osteoarthritis

Despite the increased use of platelet-rich plasma in the treatment of osteoarthritis, whether and how age of the platelet-rich plasma donor affects therapeutic efficacy is unclear. DESIGN: In vitro, male osteoarthritic human chondrocytes were treated with platelet-rich plasma from young (18–35 yrs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhary, Kuntal, Sahu, Amrita, Iijima, Hirotaka, Shinde, Sunita, Borg-Stein, Joanne, Ambrosio, Fabrisia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245083/
https://www.ncbi.nlm.nih.gov/pubmed/36480365
http://dx.doi.org/10.1097/PHM.0000000000002161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245083/
https://www.ncbi.nlm.nih.gov/pubmed/36480365
http://dx.doi.org/10.1097/PHM.0000000000002161

Ejemplares similares